Managing leprosy reactions with secukinumab: Insights from a case series
Secukinumab appears to be a promising corticosteroid-sparing option for ENL, with a favorable safety profile. Further studies are required to confirm the efficacy and long-term safety of this treatment regimen.
Authors
- Andréa Fernandes Eloy da Costa França (ORCID: https://orcid.org/0000-0003-1657-4570)
- Paulo Eduardo Neves Ferreira Velho (ORCID: https://orcid.org/0000-0001-7901-2351)
- João Paulo Turri Brufatto (ORCID: https://orcid.org/0000-0001-9752-377X)
- Luciana Vilela Gomide (ORCID: https://orcid.org/0009-0001-5465-5462)
- Thiago Jessé Kucarz (ORCID: https://orcid.org/0009-0000-7339-3026)
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Universidade Estadual de Goiás (BR)
- Universidade Federal de Goiás (BR)
Publication Details
- Journal
- Revista da Sociedade Brasileira de Medicina Tropical
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1590/0037-8682-0118-2025
- Primary Topic
- Leprosy Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00